Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease – a randomized, open-label, multicenter phase II trial

Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease – a randomized, open-label, multicenter phase II trial

Abstract Background Recently, the combination of the programmed death-ligand 1 (PD-L1) inhibitor atezolizumab with first-line chemotherapy has demonstrated to improve outcome for patients with advanced small cell lung cancer (SCLC), leading to approval of this regimen. At the same time, accumulating...

Full description

Bibliographic Details
Main Authors: Farastuk Bozorgmehr, Petros Christopoulos, Inn Chung, Jelena Cvetkovic, Manuel Feißt, Johannes Krisam, Marc A. Schneider, Claus Peter Heußel, Michael Kreuter, Daniel W. Müller, Michael Thomas, Stefan Rieken
Format: Article
Language:English
Published: BMC 2022-09-01
Series:BMC Cancer
Subjects:
Extensive disease small cell lung cancer
SCLC
Radioimmuntherapy
Thoracic radiotherapy
Atezolizumab
Anti-PD-L1 monoclonal antibody
Online Access:https://doi.org/10.1186/s12885-022-10074-9

Internet

https://doi.org/10.1186/s12885-022-10074-9

Similar Items